EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0K1R: Viridian Therapeutics Inc.

11 Nov 2025
LAST:

28.38

CHANGE:
 0.51		OPEN:
27.40		HIGH:
28.83		ASK:
0.00		VOLUME:
2.2K
CHG(%):
1.83		PREV:
27.87		LOW:
27.40		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Nov 2527.4028.8327.4028.382.2K
10 Nov 2527.8727.8727.5627.8790
07 Nov 2527.0027.5026.4726.981.1K
06 Nov 2525.0028.5425.0027.674.1K
05 Nov 2522.8024.7422.8024.36771
04 Nov 2522.2522.7222.2522.304.4K
03 Nov 2523.5023.7823.0923.392.1K
31 Oct 2523.9524.0223.8224.02364
30 Oct 2523.0524.0423.0523.661.3K
29 Oct 2523.5623.5622.8723.05225

COMPANY PROFILE

Name:Viridian Therapeutics Inc.
About:Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Address:221 Crescent Street, Waltham, MA, United States, 02453
Website:https://www.viridiantherapeutics.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:4.79 
PEG Ratio:0.10 
Price to Sales:0.20 
Price to Book:5.71 
Profit Margin:0.53 
Operating Margin:-1,423.56 
Return on Assets:-0.40 
Return on Equity:-0.66 
EPS Ratio:-5.14 
Revenue:305.0K 
EBITDA:1.275B 
Shares:30.84M 
Market Cap:875.23M 

TECHNICAL INDICATORS

MA5:27.054.9%
MA10:25.1712.8%
MA20:24.0018.3%
MA50:21.6431.1%
MA100:19.3546.6%
MA200:17.0566.4%
STO9:93.09 
STO14:93.46 
RSI14:77.50 
MTM14:6.23
ROC14:0.28 
ATR:1.21 
Week High:28.831.6%
Week Low:22.2527.6%
Month High:28.831.6%
Month Low:20.8166.4%
Year High:28.831.6%
Year Low:9.99184.1%
Volatility:24.82 

RECENT SPLITS

Date Ratio
13 Nov 20200.066667-1

RECENT DIVIDENDS

Date Amount
28 Mar 2022$1.26
29 Mar 2021$0.71
29 Jun 2020$5.40
27 Mar 2020$10.65
29 Mar 2019$9.30
10 Apr 2018$7.65
06 Apr 2018$7.65
07 Apr 2017$6.90
08 Apr 2016$5.70
10 Apr 2015$16.20